Days after US biotech company Moderna said that early data shows that their COVID-19 vaccine candidate is 94.5 percent effective, the Company’s Chief Executive Officer Stephane Bancel said that they will charge the government between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Reuters reported.
“Our vaccine, therefore, costs about the same as a flu shot, which is between $10 and $50,” Reuters quoted Bancel as saying.
Talking about the deal with the European Commission, an EU official said that they wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine for a price below $25 per dose.
Bancel said that nothing has been finalised yet, but the deal with the EU commission is almost done.
“We want to deliver to Europe and are in constructive talks,” Bancel added.
The biotech company released an interim analysis on Monday, which said that based on a study of 95 patients with confirmed COVID-19 infections, the vaccine candidate had been found to have an efficacy of 94.5 percent.
Moderna will now apply to the US regulator, the Food and Drug Administration, for emergency-use authorisation in the coming weeks, the report further said.
(With inputs from Reuters)
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)